Attached files

file filename
S-1 - FORM S-1 - Zeltiq Aesthetics Incds1.htm
EX-3.2 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Zeltiq Aesthetics Incdex32.htm
EX-3.1 - FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Zeltiq Aesthetics Incdex31.htm
EX-3.4 - FORM OF AMENDED AND RESTATED BYLAWS - Zeltiq Aesthetics Incdex34.htm
EX-3.3 - AMENDED AND RESTATED BYLAWS - Zeltiq Aesthetics Incdex33.htm
EX-4.2 - WARRANT TO PURCHASE STOCK - Zeltiq Aesthetics Incdex42.htm
EX-10.7 - LOAN AND SECURITY AGREEMENT - Zeltiq Aesthetics Incdex107.htm
EX-10.8 - FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT - Zeltiq Aesthetics Incdex108.htm
EX-23.3 - CONSENT OF EASTON ASSOCIATES, LLC - Zeltiq Aesthetics Incdex233.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP (US) - Zeltiq Aesthetics Incdex232.htm
EX-10.17 - FORM OF INDEMNIFICATION AGREEMENT - Zeltiq Aesthetics Incdex1017.htm
EX-10.23 - THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - Zeltiq Aesthetics Incdex1023.htm
EX-10.10 - MANUFACTURING SERVICES AGREEMENT - Zeltiq Aesthetics Incdex1010.htm
EX-10.18 - OFFER LETTER AGREEMENT - Zeltiq Aesthetics Incdex1018.htm
EX-10.20 - OFFER LETTER AGREEMENT - Zeltiq Aesthetics Incdex1020.htm

EXHIBIT 23.4

July 11, 2011

John Howe

Chief Financial Officer and Senior Vice President

ZELTIQ Aesthetics, Inc.

4698 Willow Road, Suite 100

Pleasanton, CA 94588

Rabin Research Company hereby consents to references to our name in the Registration Statement on Form S-1 to be filed with the U.S. Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended, in connection with the initial public offering of shares of common stock of ZELTIQ Aesthetics, Inc. (“ZELTIQ”). We consent to the use in the sections of the Registration Statement entitled “Prospectus Summary—Our Solution” and “Business—Our Solution” of our name and the data sourced from the survey performed by us dated July 6, 2011 as commissioned by ZELTIQ, including:

In a survey of 1,076 adults in the U.S. that we conducted through the Rabin Research Company, an independent full-service marketing research company, more than 40% of the participants indicated that they were likely to seek more information about the CoolSculpting procedure to enhance the shape of their body. We achieved this positive response despite the fact that 90% of the participants in our survey had never previously elected to undergo an aesthetic procedure and exactly 50% were men, a group that accounted for less than 10% of the total aesthetic procedures performed in the United States in 2010.

We hereby consent to the filing of this letter as an exhibit to the Registration Statement.

 

RABIN RESEARCH COMPANY
By:   /s/ Michelle Elster
  Name: Michelle Elster
  Title: Vice President